Analyst Ratings for Inspire Medical Systems (INSP)
INSP Rating Summary
INSP Price Target Summary
- Highest: $150.00 (Lake Street )
- Lowest: $60.00 (Morgan Stanley)
- Average: $86.93
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$86.93 (+38%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$86.93 (+38%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/13/2026 | Wolfe Research | Mike Polark | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
59.65 (62.99) |
5.6% | Details |
| 2/12/2026 | Nephron | Chris Pasquale | Downgrade | Hold (Buy) |
N/A (N/A) |
68.21 (62.99) |
-7.65% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


